Cargando…
Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of gluco...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067136/ https://www.ncbi.nlm.nih.gov/pubmed/32190015 http://dx.doi.org/10.4103/wjnm.WJNM_58_18 |
_version_ | 1783505354267557888 |
---|---|
author | Sarikaya, Ismet Sharma, Prem N. Sarikaya, Ali Elgazzar, Abdelhamid H. |
author_facet | Sarikaya, Ismet Sharma, Prem N. Sarikaya, Ali Elgazzar, Abdelhamid H. |
author_sort | Sarikaya, Ismet |
collection | PubMed |
description | Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of glucose to be given is not detailed well. In this retrospective study, we aimed to assess if certain parameters, particularly the amount of glucose and insulin given, may affect (18)F-FDG uptake in the hibernating myocardium and also determine the problems with this protocol. (18)F-FDG PET cardiac viability study with G/I loading protocols was performed in 49 patients. Fasting blood glucose (FBG), amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection were recorded. Statistical analysis was performed to determine if there is any difference in the above values in PET viable and PET nonviable groups and also in subgroups assessing (18)F-FDG uptake also in normal myocardium. For G/I loading, we used our local protocol in 43 patients, and other protocols in six. (18)F-FDG PET showed viability in 31 patients, and it was negative for viability in 18. In 22 patients, mainly in PET viable group, there was varying degree of reduced (18)F-FDG uptake in normal myocardium. There was no significant difference in FBG, amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection in PET viable and PET nonviable groups and also in subgroups. The problems with G/I loading protocol included deciding on the amounts of glucose and insulin given, maximum amount of insulin to be given, handling diabetics, optimal time to measure blood glucose after insulin administration, and interpretation of findings in cases with diffusely reduced (18)F-FDG uptake. Further improvements in current guidelines are necessary to obtain images in optimal conditions for accurate results. |
format | Online Article Text |
id | pubmed-7067136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-70671362020-03-18 Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies Sarikaya, Ismet Sharma, Prem N. Sarikaya, Ali Elgazzar, Abdelhamid H. World J Nucl Med Original Article Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of glucose to be given is not detailed well. In this retrospective study, we aimed to assess if certain parameters, particularly the amount of glucose and insulin given, may affect (18)F-FDG uptake in the hibernating myocardium and also determine the problems with this protocol. (18)F-FDG PET cardiac viability study with G/I loading protocols was performed in 49 patients. Fasting blood glucose (FBG), amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection were recorded. Statistical analysis was performed to determine if there is any difference in the above values in PET viable and PET nonviable groups and also in subgroups assessing (18)F-FDG uptake also in normal myocardium. For G/I loading, we used our local protocol in 43 patients, and other protocols in six. (18)F-FDG PET showed viability in 31 patients, and it was negative for viability in 18. In 22 patients, mainly in PET viable group, there was varying degree of reduced (18)F-FDG uptake in normal myocardium. There was no significant difference in FBG, amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection in PET viable and PET nonviable groups and also in subgroups. The problems with G/I loading protocol included deciding on the amounts of glucose and insulin given, maximum amount of insulin to be given, handling diabetics, optimal time to measure blood glucose after insulin administration, and interpretation of findings in cases with diffusely reduced (18)F-FDG uptake. Further improvements in current guidelines are necessary to obtain images in optimal conditions for accurate results. Wolters Kluwer - Medknow 2020-02-27 /pmc/articles/PMC7067136/ /pubmed/32190015 http://dx.doi.org/10.4103/wjnm.WJNM_58_18 Text en Copyright: © 2020 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Sarikaya, Ismet Sharma, Prem N. Sarikaya, Ali Elgazzar, Abdelhamid H. Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title | Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title_full | Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title_fullStr | Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title_full_unstemmed | Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title_short | Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies |
title_sort | assessing oral glucose and intravenous insulin loading protocol in (18)f-fluorodeoxyglucose positron emission tomography cardiac viability studies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067136/ https://www.ncbi.nlm.nih.gov/pubmed/32190015 http://dx.doi.org/10.4103/wjnm.WJNM_58_18 |
work_keys_str_mv | AT sarikayaismet assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies AT sharmapremn assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies AT sarikayaali assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies AT elgazzarabdelhamidh assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies |